TD Waterhouse Canada Inc. Boosts Position in Axon Enterprise, Inc $AXON

TD Waterhouse Canada Inc. lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 19.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,915 shares of the biotechnology company’s stock after acquiring an additional 1,261 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in Axon Enterprise were worth $4,700,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Brighton Jones LLC purchased a new position in shares of Axon Enterprise in the fourth quarter valued at $480,000. NewEdge Advisors LLC grew its stake in Axon Enterprise by 41.1% in the first quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock worth $1,207,000 after purchasing an additional 668 shares in the last quarter. Empowered Funds LLC grew its position in shares of Axon Enterprise by 8.4% in the 1st quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock worth $1,067,000 after acquiring an additional 157 shares in the last quarter. Woodline Partners LP boosted its holdings in Axon Enterprise by 40.6% in the first quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock worth $3,646,000 after purchasing an additional 2,003 shares during the period. Finally, Sivia Capital Partners LLC acquired a new position in shares of Axon Enterprise in the 2nd quarter valued at about $284,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In related news, President Joshua Isner sold 16,775 shares of the firm’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $574.43, for a total value of $9,636,063.25. Following the transaction, the president directly owned 296,974 shares in the company, valued at approximately $170,590,774.82. This trade represents a 5.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 9,930 shares of Axon Enterprise stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $548.77, for a total value of $5,449,286.10. Following the completion of the transaction, the chief executive officer owned 3,031,067 shares in the company, valued at $1,663,358,637.59. The trade was a 0.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 56,380 shares of company stock worth $32,582,366. 4.20% of the stock is owned by corporate insiders.

Axon Enterprise Price Performance

AXON opened at $515.67 on Monday. The stock has a market cap of $41.89 billion, a price-to-earnings ratio of 213.97, a PEG ratio of 10.06 and a beta of 1.40. The stock has a fifty day moving average price of $569.47 and a 200 day moving average price of $486.64. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $792.16. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. The firm had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The firm’s revenue was up 35.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.12 earnings per share. Analysts forecast that Axon Enterprise, Inc will post 2.04 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently commented on AXON shares. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Zacks Research lowered shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 10th. TD Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a report on Wednesday, July 22nd. Piper Sandler upped their price target on Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Finally, Barclays boosted their price objective on Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $721.57.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.